MicroRNA targeting energy metabolism in ovarian cancer: a potent contender for future therapeutics.
作者信息
Pareek Siddhika, Nath Aritro, Huang R Stephanie
机构信息
Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN, USA.
Department of Medical Oncology and Therapeutics Research, City of Hope, Monrovia, CA, USA.
出版信息
Ann Transl Med. 2019 Dec;7(Suppl 8):S299. doi: 10.21037/atm.2019.11.15.
Abstract
摘要
相似文献
1
MicroRNA targeting energy metabolism in ovarian cancer: a potent contender for future therapeutics.
Ann Transl Med. 2019 Dec;7(Suppl 8):S299. doi: 10.21037/atm.2019.11.15.
2
The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation.瘦素刺激通过靶向叉头框 O3 上调信号转导和转录激活因子 5 依赖性 microRNA-182 和 microRNA-96，促进卵巢癌细胞增殖。
Int J Biochem Cell Biol. 2013 Mar;45(3):536-45. doi: 10.1016/j.biocel.2012.12.010. Epub 2012 Dec 20.
3
MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN.微小 RNA-200a 通过靶向 PTEN 促进卵巢癌细胞的增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6260-6267. doi: 10.26355/eurrev_201810_16033.
4
LncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p.LncSNHG14 通过靶向 microRNA-125a-5p 促进卵巢癌。
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3235-3242. doi: 10.26355/eurrev_201904_17683.
5
MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ.miRNA-802 通过靶向 YWHAZ 抑制上皮性卵巢癌细胞的增殖和迁移。
J Ovarian Res. 2019 Oct 22;12(1):100. doi: 10.1186/s13048-019-0576-3.
6
MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1.微小RNA-144通过直接靶向葡萄糖转运蛋白1介导卵巢癌细胞的代谢转变。
Tumour Biol. 2016 May;37(5):6855-60. doi: 10.1007/s13277-015-4558-9. Epub 2015 Dec 11.
7
miRNAs and ovarian cancer: An overview.miRNAs 与卵巢癌：概述。
J Cell Physiol. 2018 May;233(5):3846-3854. doi: 10.1002/jcp.26095. Epub 2017 Aug 25.
8
The prognostic role of microRNA in epithelial ovarian cancer: a systematic review of literature with an overall survival meta-analysis.微小RNA在上皮性卵巢癌中的预后作用：一项文献系统综述及总生存的Meta分析
Oncotarget. 2020 Mar 24;11(12):1085-1095. doi: 10.18632/oncotarget.27246.
9
Engineered microRNA therapeutics.工程化微小RNA疗法
J R Coll Physicians Edinb. 2014;44(3):196-200. doi: 10.4997/JRCPE.2014.302.
10
MiR-542-3p, a microRNA targeting CDK14, suppresses cell proliferation, invasiveness, and tumorigenesis of epithelial ovarian cancer.miR-542-3p 通过靶向 CDK14 抑制上皮性卵巢癌细胞的增殖、侵袭和致瘤性。
Biomed Pharmacother. 2019 Feb;110:850-856. doi: 10.1016/j.biopha.2018.11.104. Epub 2018 Dec 14.
引用本文的文献
1
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer.进展性高级别浆液性卵巢癌核心典型表型的演变。
Nat Commun. 2021 May 24;12(1):3039. doi: 10.1038/s41467-021-23171-3.
本文引用的文献
1
miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism.miR-450a 通过调节能量代谢在卵巢癌中发挥肿瘤抑制作用。
Cancer Res. 2019 Jul 1;79(13):3294-3305. doi: 10.1158/0008-5472.CAN-19-0490. Epub 2019 May 17.
2
EMT in cancer.肿瘤中的 EMT。
Nat Rev Cancer. 2018 Feb;18(2):128-134. doi: 10.1038/nrc.2017.118. Epub 2018 Jan 12.
3
Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer.糖酵解和谷氨酰胺分解的双重抑制作为卵巢癌治疗的一种策略
Oncotarget. 2017 Jun 29;8(38):63551-63561. doi: 10.18632/oncotarget.18854. eCollection 2017 Sep 8.
4
Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancer.谷氨酰胺酶抑制剂化合物968抑制卵巢癌细胞增殖并增强紫杉醇的敏感性。
Am J Transl Res. 2016 Oct 15;8(10):4265-4277. eCollection 2016.
5
Fundamentals of cancer metabolism.癌症代谢基础。
Sci Adv. 2016 May 27;2(5):e1600200. doi: 10.1126/sciadv.1600200. eCollection 2016 May.
6
Emerging and Evolving Ovarian Cancer Animal Models.新兴和不断发展的卵巢癌动物模型
Cancer Growth Metastasis. 2015 Aug 12;8(Suppl 1):29-36. doi: 10.4137/CGM.S21221. eCollection 2015.
7
Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway.谷氨酰胺通过mTOR/S6信号通路促进卵巢癌细胞增殖。
Endocr Relat Cancer. 2015 Aug;22(4):577-91. doi: 10.1530/ERC-15-0192. Epub 2015 Jun 4.
8
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer.代谢向谷氨酰胺的转变调节卵巢癌的肿瘤生长、侵袭和生物能量学。
Mol Syst Biol. 2014 May 5;10(5):728. doi: 10.1002/msb.20134892.
9
Metabolic changes during ovarian cancer progression as targets for sphingosine treatment.卵巢癌进展过程中的代谢变化及其作为神经酰胺治疗靶点的研究进展。
Exp Cell Res. 2013 Jun 10;319(10):1431-42. doi: 10.1016/j.yexcr.2013.02.017. Epub 2013 Mar 19.
10
Regulation of cancer cell metabolism.癌细胞代谢的调控。
Nat Rev Cancer. 2011 Feb;11(2):85-95. doi: 10.1038/nrc2981.
Zotero 插件